(Q35166848)

6 August 2017

1 reference

title

Chronic myelogenous leukemia as a paradigm of early cancer and possible curative strategies (English)

1 reference

6 August 2017

1 reference

Clarkson B

1

1 reference

6 August 2017

Strife A

2

1 reference

6 August 2017

Wisniewski D

3

1 reference

6 August 2017

Lambek CL

4

1 reference

6 August 2017

Liu C

5

1 reference

6 August 2017

publication date

1 July 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

17

1 reference

6 August 2017

issue

7

1 reference

6 August 2017

page(s)

1211-1262

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.leu.2402912

6 August 2017

exact match

0 references

cites work

Ueber rothes Knochenmark und Myeloblasten

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Detection of c-abl tyrosine kinase activity in vitro permits direct comparison of normal and altered abl gene products

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Involvement of chromosome 9 in variant Ph1 translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

The Philadelphia chromosome: a model of cancer and molecular cytogenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Persistence of chronic myelocytic leukemia despite deletion of rearranged bcr/c-abl sequences in blast crisis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

The karyotype of blastic crisis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Variant (3;21) translocation and megakaryocytic involvement in blastic crisis of Philadelphia positive chronic myeloid leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Possible cytogenetic distinction between lymphoid and myeloid blast crisis in chronic granulocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

The spectrum of molecular alterations in the evolution of chronic myelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

NUP98 gene rearrangements and the clonal evolution of chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

The biology of chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Blast crisis of chronic myeloid leukaemia (CML). II. Cell surface marker analysis of "lymphoid" and myeloid cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

The age distribution of cancer and a multi-stage theory of carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Cancer and ageing in mice and men

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Genetic alterations during colorectal-tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

What Is the Evidence That Tumors Are Angiogenesis Dependent?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

The clonal evolution of tumor cell populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Disorders in cell circuitry during multistage carcinogenesis: the role of homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Cancer. Addiction to oncogenes--the Achilles heal of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Clonal origin of chronic myelocytic leukemia in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Clonal Origin of the Philadelphia Chromosome and Chronic Myeloid Leukaemia: Evidence from a Sex Chromosome Mosaic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Clonality in myeloproliferative disorders: analysis by means of the polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Variable expression of the translocated c-abl oncogene in Philadelphia-chromosome-positive B-lymphoid cell lines from chronic myelogenous leukemia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Turning brain into blood: a hematopoietic fate adopted by adult neural stem cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Muscle regeneration by bone marrow-derived myogenic progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Pluripotency of mesenchymal stem cells derived from adult marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Acquisition of a Philadelphia chromosome concomitant with transformation of a refractory anemia into an acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

B-lymphoid cell involvement in chronic myelogenous leukemia: implications for the pathogenesis of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Cytokinetic considerations relevant to development of a successful therapeutic strategy in chronic myelogenous leukemia (CML).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Inhibition of constitutively active forms of mutant kit by multitargeted indolinone tyrosine kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Fetal origins of the TEL-AML1 fusion gene in identical twins with leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Molecular tracking of leukemogenesis in a triplet pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Chromosome translocations and covert leukemic clones are generated during normal fetal development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

BCR-ABL insufficiency for the transformation of human stem cells into CML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Blast crisis in a murine model of chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Acute leukaemia in bcr/abl transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Tyrosine kinase activity and transformation potency of bcr-abl oncogene products.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

The src homology 2 domain of Bcr/Abl is required for efficient induction of chronic myeloid leukemia-like disease in mice but not for lymphoid leukemogenesis or activation of phosphatidylinositol 3-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Establishment of a murine model for therapy-treated chronic myelogenous leukemia using the tyrosine kinase inhibitor STI571.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

The SH2 domain of bcr-Abl is not required to induce a murine myeloproliferative disease; however, SH2 signaling influences disease latency and phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Dissecting the molecular mechanism of chronic myelogenous leukemia using murine models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Regulated expression of P210 Bcr-Abl during embryonic stem cell differentiation stimulates multipotential progenitor expansion and myeloid cell fate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

The Abl family kinases: mechanisms of regulation and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

The BCR gene encodes a novel serine/threonine kinase activity within a single exon

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Activation of tyrosinase kinase and microfilament-binding functions of c-abl by bcr sequences in bcr/abl fusion proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

BCR sequences essential for transformation by the BCR-ABL oncogene bind to the ABL SH2 regulatory domain in a non-phosphotyrosine-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Tyrosine kinase oncogenes in normal hematopoiesis and hematological disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Localization and phosphorylation of Abl-interactor proteins, Abi-1 and Abi-2, in the developing nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Essential roles for the Abl and Arg tyrosine kinases in neurulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

The beta-amyloid precursor protein APP is tyrosine-phosphorylated in cells expressing a constitutively active form of the Abl protoncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Cell cycle-regulated binding of c-Abl tyrosine kinase to DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

The human leukemia oncogene bcr-abl abrogates the anchorage requirement but not the growth factor requirement for proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Nuclear tyrosine kinases: from Abl to WEE1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

The mouse type IV c-abl gene product is a nuclear protein, and activation of transforming ability is associated with cytoplasmic localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

The amphiphysin-like protein 1 (ALP1) interacts functionally with the cABL tyrosine kinase and may play a role in cytoskeletal regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

BCR/ABL induces multiple abnormalities of cytoskeletal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Bcr encodes a GTPase-activating protein for p21rac

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Bcr: a negative regulator of the Bcr-Abl oncoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

c-Abl is activated by growth factors and Src family kinases and has a role in the cellular response to PDGF

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

BCR-ABL and v-SRC tyrosine kinase oncoproteins support normal erythroid development in erythropoietin receptor-deficient progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Structural basis for the autoinhibition of c-Abl tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Association of the protein kinases c-Bcr and Bcr-Abl with proteins of the 14-3-3 family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Chromosomal localization of human cellular homologues of two viral oncogenes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

The molecular genetics of Philadelphia chromosome-positive leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Evidence of a new chimeric bcr/c-abl mRNA in patients with chronic myelocytic leukemia and the Philadelphia chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Localization of preferential sites of rearrangement within the BCR gene in Philadelphia chromosome-positive acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Heterogeneity of chromosome 22 breakpoint in Philadelphia-positive (Ph+) acute lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Unique fusion of bcr and c-abl genes in Philadelphia chromosome positive acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Molecular pathogenesis of Ph-positive leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

The CML-specific P210 bcr/abl protein, unlike v-abl, does not transform NIH/3T3 fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

In vitro transformation of immature hematopoietic cells by the P210 BCR/ABL oncogene product of the Philadelphia chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Alternative forms of the BCR-ABL oncogene have quantitatively different potencies for stimulation of immature lymphoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Chronic Neutrophilic Leukemia: Report of Two Cases and Review of the Literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Point mutations in the abl SH2 domain coordinately impair phosphotyrosine binding in vitro and transforming activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Mutagenic analysis of the roles of SH2 and SH3 domains in regulation of the Abl tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

SH2 domains recognize specific phosphopeptide sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Modular peptide recognition domains in eukaryotic signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Protein modules and signalling networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Cellular functions regulated by Src family kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

A tail of two src's: mutatis mutandis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Structures of Src-family tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Three-dimensional structure of the tyrosine kinase c-Src

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Crystal structure of Hck in complex with a Src family-selective tyrosine kinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Phosphorylation and structure-based functional studies reveal a positive and a negative role for the activation loop of the c-Abl tyrosine kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

The protein kinases of budding yeast: six score and more

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

The protein kinases of Caenorhabditis elegans: a model for signal transduction in multicellular organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Signaling--2000 and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Oncogenes and signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

p62(dok): a constitutively tyrosine-phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

New understanding of the pathogenesis of CML: a prototype of early neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

JAKs, STATs and Src kinases in hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Signal transduction by receptors with tyrosine kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

1002 protein phosphatases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Mammalian SH2-containing protein tyrosine phosphatases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Identification of PTP1C mutation as the genetic defect in motheaten and viable motheaten mice: a step toward defining the roles of protein tyrosine phosphatases in the regulation of hemopoietic cell differentiation and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

SHP-1 regulation of p62(DOK) tyrosine phosphorylation in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Imatinib mesylate (STI571) inhibits growth of primitive malignant progenitors in chronic myelogenous leukemia through reversal of abnormally increased proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Molecular themes in oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Signaling through scaffold, anchoring, and adaptor proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Signalling through the lipid products of phosphoinositide-3-OH kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Cell lines and peripheral blood leukocytes derived from individuals with chronic myelogenous leukemia display virtually identical proteins phosphorylated on tyrosine residues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Phosphotyrosine antibodies identify the p210c-abl tyrosine kinase and proteins phosphorylated on tyrosine in human chronic myelogenous leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Crkl is complexed with tyrosine-phosphorylated Cbl in Ph-positive leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Coupling between p210bcr-abl and Shc and Grb2 adaptor proteins in hematopoietic cells permits growth factor receptor-independent link to ras activation pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Shc proteins are phosphorylated and regulated by the v-Src and v-Fps protein-tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

The BCR/ABL oncogene alters interaction of the adapter proteins CRKL and CRK with cellular proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

The phosphatidylinositol polyphosphate 5-phosphatase SHIP and the protein tyrosine phosphatase SHP-2 form a complex in hematopoietic cells which can be regulated by BCR/ABL and growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Molecular cloning and characterization of p56dok-2 defines a new family of RasGAP-binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Pten is essential for embryonic development and tumour suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

The phosphatidylinositol polyphosphate 5-phosphatase SHIP1 associates with the dok1 phosphoprotein in bcr-Abl transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Tyrosine kinase oncogenes abrogate interleukin-3 dependence of murine myeloid cells through signaling pathways involving c-myc: conditional regulation of c-myc transcription by temperature-sensitive v-abl

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Transcriptional activation of a ras-like gene (kir) by oncogenic tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Phosphatidylinositol 3-kinase and Src family kinases are required for phosphorylation and membrane recruitment of Dok-1 in c-Kit signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

BCR-ABL and interleukin 3 promote haematopoietic cell proliferation and survival through modulation of cyclin D2 and p27Kip1 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Chronic myelogenous leukemia: biology and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

21 January 2018

Chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Functional and biochemical phenotype in relation to cellular age of differentiated neutrophils in chronic myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Quantitative measurement of hematopoietic cells of the marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Human chemokines: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Regulation of hematopoiesis in a sea of chemokine family members with a plethora of redundant activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Hematopoietic stem/progenitor cell mobilization. A continuing quest for etiologic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Normal content of brain spectrin-like protein in sph/sph mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Megakaryoblastic micromegakaryocytic crisis in chronic myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Bone marrow sinus and cell egress in human leukaemia: a morphometric study of core biopsies using wide-field electron microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

21 January 2018

The marrow-blood barrier

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

The local exudative cellular response in leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Granulocyte function in chronic granulocytic leukaemia. I. Bactericidal and metabolic capabilities during phagocytosis in isolated granulocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Progressive loss of phenotypic proteins in mature granulocytes before the onset of blast crisis in human chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Defective Hydrogen Peroxide Production in Chronic Granulocytic Leukaemia Neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

The Function of the Phagocytic Leucocytes in Leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Studies on neutrophil function. II. Pathological aspects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Neutrophil function in chronic granulocytic leukaemia before and after busulphan treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Plasma membrane proteins from human normal and chronic myeloid leukemic granulocytes: identification and partial characterization of the concanavalin A-binding and detergent resistant proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Unregulated proliferation of primitive chronic myeloid leukemia progenitors in the presence of normal marrow adherent cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia. Decreased adhesion to stroma and fibronectin but increased adhesion to the basement membrane components laminin and collagen type IV

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Treatment of marrow stroma with interferon-alpha restores normal beta 1 integrin-dependent adhesion of chronic myelogenous leukemia hematopoietic progenitors. Role of MIP-1 alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Changes in the granulocyte membrane following chemotherapy for chronic myelogenous leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Chronic myelogenous leukemia primitive hematopoietic progenitors demonstrate increased sensitivity to growth factor-induced proliferation and maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Stem cell self-renewal specified by JAK-STAT activation in response to a support cell cue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Somatic control over the germline stem cell lineage during Drosophila spermatogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Control of stem cell self-renewal in Drosophila spermatogenesis by JAK-STAT signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

STAT3 activation is sufficient to maintain an undifferentiated state of mouse embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Clonal and systemic analysis of long-term hematopoiesis in the mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Stem cells, pre-progenitor cells and lineage-committed cells: are our dogmas correct?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

The relative spatial distribution of in vitro-CFCs in the bone marrow, responding to specific growth factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

In vitro colony formation by normal and leukemic human hematopoietic cells: characterization of the colony-forming cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Stem cell repopulation efficiency but not pool size is governed by p27(kip1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

BCR/ABL regulates expression of the cyclin-dependent kinase inhibitor p27Kip1 through the phosphatidylinositol 3-Kinase/AKT pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

LEUKOKINETIC STUDIES. X. BLOOD GRANULOCYTE KINETICS IN CHRONIC MYELOCYTIC LEUKEMIA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

A neutrophil cycle in healthy individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Cyclophosphamide-induced cyclical neutropenia. An animal model of a human periodic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Familial Cyclical Neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Occurrence of periodic oscillations in the differential blood counts of congenital, idiopathic, and cyclical neutropenic patients before and during treatment with G-CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Periodic chronic myelogenous leukaemia: spectral analysis of blood cell counts and aetiological implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Cyclic leucocytosis as evidence for retention of normal homoeostatic control in chronic granulocytic leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Cyclic leukemic cell production in CML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Spontaneous Cyclic Leukocytosis and Thrombocytosis in Chronic Granulocytic Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Modeling complex neutrophil dynamics in the grey collie.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Studies of leukocyte kinetics by liquid scintillation counting in normal individuals and in patients with chronic myelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Programmed cell death—II. Endocrine potentiation of the breakdown of the intersegmental muscles of silkmoths

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr/abl protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Structural and signaling requirements for BCR-ABL-mediated transformation and inhibition of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Expression of CD95(FAS) by gene transfer does not sensitize K562 to Fas-killing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Bcl-2 mRNA-targeted ribozymes: effects on programmed cell death in chronic myelogenous leukemia cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

The susceptibility of Philadelphia chromosome positive cells to FAS-mediated apoptosis is not linked to the tyrosine kinase activity of BCR-ABL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Blockade of the Bcr-Abl kinase activity induces apoptosis of chronic myelogenous leukemia cells by suppressing signal transducer and activator of transcription 5-dependent expression of Bcl-xL

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

p53 loss and point mutations are associated with suppression of apoptosis and progression of CML into myeloid blastic crisis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Bcl-2-independent Bcr-Abl-mediated resistance to apoptosis: protection is correlated with up regulation of Bcl-xL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Cell biology of CML cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Induction of apoptosis in chronic myelogenous leukemia cells through nuclear entrapment of BCR-ABL tyrosine kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Regulation of cell death by the Abl tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Differences in the composition and in the efficiency of red cell production of normal and CML erythroid progenitor populations are highlighted by response to human c-kit ligand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Studies of Cellular Proliferation in Human Leukemia. I. Estimation of Growth Rates of Leukemic and Normal Hematopoietic Cells in Two Adults with Acute Leukemia Given Single Injections of Tritiated Thymidine *

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Studies of cellular proliferation in human leukemia. IV. Behavior of normal hemotopoietic cells in 3 adults with acute leukemia given continuous infusions of 3H-thymidine for 8 or 10 days

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

The kinetic significance of cell size, I. Variation of cell cycle parameters with size measured at mitosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

The kinetic significance of cell size. II. Size distributions of resting and proliferating cells during interphase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Elucidating critical mechanisms of deregulated stem cell turnover in the chronic phase of chronic myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Chronic myelogenous leukemia: in vitro studies of hematopoietic regulation in a patient undergoing intensive chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Abnormal kinetics of colony formation by erythroid burst-forming units (BFU-E) in chronic myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Development of a binding model to protein tyrosine kinases for substituted pyrido[2,3-d]pyrimidine inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Characterization of two novel sublines established from a human megakaryoblastic leukemia cell line transfected with p210(BCR-ABL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Stem cell factor and chronic myeloid leukemia CD34+ cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

BCR-ABL alters the proliferation and differentiation response of multipotent hematopoietic cells to stem cell factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Long-term survivors in chronic granulocytic leukaemia: a study by the International CGL Prognosis Study Group. Italian Cooperative CML Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Survival in chronic myelogenous leukemia: Influence of treatment and extent of disease at diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Upper and lower time limits in the decision to recommend marrow transplantation for patients with chronic myelogenous leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

13-cis-Retinoic acid does not increase the true remission rate and the duration of true remission (induced by cytotoxic chemotherapy) in patients with chronic phase chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Inhibition by retinoic acid of myeloid progenitors in chronic myeloid leukemia and myeloproliferative disease: increased sensitivity in blastic phase of chronic myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

The "Retinoic Acid Syndrome" in Acute Promyelocytic Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

UK Medical Research Council randomised, multicentre trial of interferon-alpha n1 for chronic myeloid leukaemia: improved survival irrespective of cytogenetic response. The UK Medical Research Council's Working Parties for Therapeutic Trials in Adult

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Interferon-alpha therapy for chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. Writing Committee for the Collaborative CML Prognostic Factors Project Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Does long-term culture favor normal clonogenic cells from interferon-treated patients with chronic myelogenous leukemia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Results of a phase II trial of a combination of oral cytarabine ocfosfate (YNK01) and interferon alpha-2b for the treatment of chronic myelogenous leukemia patients in chronic phase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Autotransplants in chronic myelogenous leukaemia: strategies and results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Selective Inhibition of Leukemia Cell Proliferation by BCR-ABL Antisense Oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Peptide containing the BCR oligomerization domain (AA 1-160) reverses the transformed phenotype of p210bcr-abl positive 32D myeloid leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

The coiled-coil domain and Tyr177 of bcr are required to induce a murine chronic myelogenous leukemia-like disease by bcr/abl.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Low NAD(P)H:quinone oxidoreductase activity is associated with increased risk of leukemia with MLL translocations in infants and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Mutant forms of growth factor-binding protein-2 reverse BCR-ABL-induced transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Regulation of the Erk2-Elk1 signaling pathway and megakaryocytic differentiation of Bcr-Abl(+) K562 leukemic cells by Gab2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Scaffolding protein Gab2 mediates differentiation signaling downstream of Fms receptor tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Critical role for Gab2 in transformation by BCR/ABL

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

T-cell immunity to the joining region of p210BCR-ABL protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Antibody recognition of the tumor-specific bcr-abl joining region in chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Sensitivity to the abl inhibitor STI571 in fresh leukaemic cells obtained from chronic myelogenous leukaemia patients in different stages of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Mechanisms of autoinhibition and STI-571/imatinib resistance revealed by mutagenesis of BCR-ABL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

BCR-ABL gene mutations in relation to clinical resistance of Philadelphia-chromosome-positive leukaemia to STI571: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

In vitro cytotoxic effects of a tyrosine kinase inhibitor STI571 in combination with commonly used antileukemic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Multifaceted approach to the treatment of bcr-abl-positive leukemias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Activity of the farnesyl protein transferase inhibitor SCH66336 against BCR/ABL-induced murine leukemia and primary cells from patients with chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Synergistic activity of the new ABL-specific tyrosine kinase inhibitor STI571 and chemotherapeutic drugs on BCR-ABL-positive chronic myelogenous leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Structural mechanism for STI-571 inhibition of abelson tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Transformation of myeloid leukemia cells to cytokine independence by Bcr-Abl is suppressed by kinase-defective Hck

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

The Src family kinase Hck interacts with Bcr-Abl by a kinase-independent mechanism and phosphorylates the Grb2-binding site of Bcr

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr-Abl signal transduction and oncogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Consequences of BCR-ABL expression within the hematopoietic stem cell in chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

The chiaroscuro stem cell: a unified stem cell theory

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Cytokine manipulation of primitive human hematopoietic cell self-renewal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

KDR receptor: a key marker defining hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

CD34 Expression by Murine Hematopoietic Stem Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Treatment of Bcr/Abl-positive acute lymphoblastic leukemia in P190 transgenic mice with the farnesyl transferase inhibitor SCH66336.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

CDK inhibitors: positive and negative regulators of G1-phase progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Preferential induction of apoptosis for primary human leukemic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Co-treatment with As2O3 enhances selective cytotoxic effects of STI-571 against Brc-Abl-positive acute leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

The synthesis, discovery, and development of a highly promising class of microtubule stabilization agents: curative effects of desoxyepothilones B and F against human tumor xenografts in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

A cause-specific hazard rate analysis of prognostic factors among 199 adults with acute lymphoblastic leukemia: the Memorial Hospital experience since 1969.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Acute lymphoblastic leukemia in adults and children. Differences in response with similar therapeutic regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Prophylactic heparin therapy in acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

The unique aspects of acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

All-trans retinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Advances in the management of acute promyelocytic leukemia and other hematologic malignancies with arsenic trioxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Molecular targets of arsenic trioxide in malignant cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Three-dimensional solution structure of the src homology 2 domain of c-abl

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Variable numbers of BCR-ABL transcripts persist in CML patients who achieve complete cytogenetic remission with interferon-α

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Chronic Myeloid Leukemia with Increased Granulocyte Progenitors in Mice Lacking JunB Expression in the Myeloid Lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Comparative Outcomes of T-Cell–Depleted and Non–T-Cell–Depleted Allogeneic Bone Marrow Transplantation for Chronic Myelogenous Leukemia: Impact of Donor Lymphocyte Infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Chromosomal evidence of a common stem cell in acute lymphoblastic leukemia and chronic granulocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

A comparison of the sensitivity of blood and bone marrow for the detection of minimal residual disease in chronic myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Correlation between the proportion of Philadelphia chromosome-positive metaphase cells and levels ofBCR-ABL mRNA in chronic myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

A Possible Specific Chromosome Abnormality in Human Chronic Myeloid Leukæmia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Translocation of c-abl oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Fused transcript of abl and bcr genes in chronic myelogenous leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Genomic diversity correlates with clinical variation in Ph′-negative chronic myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Chromosome Pattern of Bone Marrow Fibroblasts in Patients with Chronic Granulocytic Leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Deoxyribonucleic Acid Synthesis Time of Erythropoietic and Granulopoietic Cells in Human Beings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Return of Leucocytes to the Bone Marrow in Chronic Myelogenous Leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

Cytogenetic studies in chronic myeloid leukaemia and acute leukaemia associated with monogolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Identification of the Philadelphia chromosome as a number 22 by quinacrine mustard fluorescence analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Do oncogenes determine clinical features in chronic myeloid leukaemia?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Rearrangement in the breakpoint cluster region and the clinical course in Philadelphia-negative chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

The karyotype of Philadelphia chromosome-negative, bcr rearrangement-positive chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

A cytogenetic and molecular analysis of five variant Philadelphia translocations in chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Recurrent chromosomal defects are found in most patients with acute nonlymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Recurrent chromosomal defects are found in most patients with non-Hodgkin's-lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Significance of secondary cytogenetic changes in patients with Ph-positive chronic granulocytic leukemia in the acute phase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Karyotypic evolution in Ph-positive chronic myeloid leukemia in relation to management and disease progression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Promyelocytic blast crisis in chronic granulocytic leukemia with 15;17 translocation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Karyotypic changes during the course of blastic crisis of chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Chronic granulocytic leukemia: correlation of blastic transformation type with karyotypic evolution

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Correlation between chromosomal abnormalities and blast phenotype in the blast crisis of Ph-positive CGL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Genomic alterations involving the c-myc proto-oncogene locus during the evolution of a case of chronic granulocytic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Chronic myelogenous leukemia in the monosomic cell line of a fertile Turner syndrome mosaic (45,X/46,XX)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Chronic myelogenous leukemia in an XYY male

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

The application of X-chromosome gene probes to the diagnosis of myeloproliferative disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Multilineage involvement of Philadelphia chromosome positive acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Haemangioblast origin of chronic myeloid leukaemia?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Spontaneous remission in a patient with chronic myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Spontaneous regression of cytogenetic and haematologic anomalies in Ph1-positive chronic myelogenous leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Prolonged survival in chronic granulocytic leukaemia associated with loss of the Philadelphia chromosome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Integration of molecular and biological abnormalities in quest for selective treatment of chronic myelogenous leukemia (CML)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Nonclonal hemopoietic progenitors in a G6PD heterozygote with chronic myelogenous leukemia revealed after long-term marrow culture

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Prenatal origin of acute lymphoblastic leukaemia in children

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Implicating the bcr/abl gene in the pathogenesis of Philadelphia chromosome-positive human leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Current status of the BCR gene and its involvement with human leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

A coiled-coil oligomerization domain of Bcr is essential for the transforming function of Bcr-Abl oncoproteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

c-abl has a sequence-specific enhancer binding activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Lack of correlation between ABL-BCR expression and response to interferon-alpha in chronic myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Deletion of an N-terminal regulatory domain of the c-abl tyrosine kinase activates its oncogenic potential

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

The viral and cellular forms of the Abelson (abl) oncogene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

bcr-abl, the hallmark of chronic myeloid leukaemia in man, induces multiple haemopoietic neoplasms in mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Defective expression of the SHP-1 phosphatase in polycythemia vera

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Tyrosine phosphorylation of p95Vav in myeloid cells is regulated by GM-CSF, IL-3 and steel factor and is constitutively increased by p210BCR/ABL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Bcr-Abl oncoproteins bind directly to activators of the Ras signalling pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Chronic Myelogenous Leukemia: Disease Biology and Current and Future Therapeutic Strategies.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Geographical variation in leukaemia mortality in relation to background radiation and other factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Incidence of leukemia in atomic bomb survivors belonging to a fixed cohort in Hiroshima and Nagasaki, 1950--71. Radiation dose, years after exposure, age at exposure, and type of leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

The distribution of active bone marrow in the adult

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Studies of cellular proliferation in human leukemia. VI. The proliferative activity, generation time, and emergence time of neutrophilic granulocytes in chronic granulocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

The effect of Bcr-Abl protein tyrosine kinase on maturation and proliferation of primitive haematopoietic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

1 reference

7 January 2021

Prognostic significance of the morphological dysplastic changes in chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Ultrastructure of normal and leukemic leukocytes in human peripheral blood

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Megakaryocyte cultures in the chronic phase and in the blast crisis of chronic myeloid leukaemia: studies on the differentiation of the megakaryocyte progenitors and on the maturation of megakaryocytes in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Chronic myelocytic leukemia: ultrastructural histopathology of bone marrow from patients in the chronic phase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Relation between phagocytic activity and alkaline phosphatase content of neutrophils in chronic myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Comparative studies on localized leukocyte mobilization in patients with chronic myelocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Defective chemotaxis and adherence in granulocytes from chronic myeloid leukemia (CML) patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Phagocytosis in myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Studies on neutrophil function. 1. Physiological and pharmacological aspects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Leukocyte function in patients with leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Agglutination of granulocytes from chronic myeloid leukaemia by concanavalin A

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Differential endocytosis of fluorescein iso-thiocyanate-concanavalin A by normal and chronic myeloid leukemic granulocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

ADHESIVENESS TO GLASS AND PHAGOCYTIC ACTIVITY OF NEUTROPHILIC LEUKOCYTES IN MYELOPROLIFERATIVE DISEASES

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

The effects of interferon-alpha on the proliferation of CML progenitor cells in vitro are not related to the precise position of the M-BCR breakpoint

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Progenitor cells in the blood and marrow of patients with chronic phase chronic myeloid leukaemia respond differently to macrophage inflammatory protein-1 alpha

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Regeneration of membrane sialic acid after neuraminidase treatment of leukemic granulocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Hematopoietic stem cells expand during serial transplantation in vivo without apparent exhaustion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Cytokinetic Studies in Chronic Myeloid Leukaemia: Evidence for Early Presence of Abnormal Myeloblasts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Cell proliferation in leukemia during relapse and remission. I. DNA and RNA synthesis of leukemic cells in the bone marrow in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Defective regulation of leukemic hematopoiesis in chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Chronic myelogenous leukaemia CD34+ cells exit G0/G1 phases of cell cycle more rapidly than normal marrow CD34+ cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Granulopoiesis in chronic granulocytic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Effects of human granulocyte colony-stimulating factor in a patient with idiopathic neutropenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Hematopoietic dynamics in grey collies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Apoptosis in leukocytes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

A temperature sensitive p210 BCR-ABL mutant defines the primary consequences of BCR-ABL tyrosine kinase expression in growth factor dependent cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Fludarabine-mediated repair inhibition of cisplatin-induced DNA lesions in human chronic myelogenous leukemia-blast crisis K562 cells: induction of synergistic cytotoxicity independent of reversal of apoptosis resistance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Herbimycin A accelerates the induction of apoptosis following etoposide treatment or γ-irradiation of bcr/abl-positive leukaemia cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Bcl-2 and c-myc expression, cell cycle kinetics and apoptosis during the progression of chronic myelogenous leukemia from diagnosis to blastic phase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Primary proliferating immature myeloid cells from CML patients are not resistant to induction of apoptosis by DNA damage and growth factor withdrawal

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Apoptosis in chronic myeloid leukaemia: normal responses by progenitor cells to growth factor deprivation, X-irradiation and glucocorticoids

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

The tyrosine kinase inhibitor STI571, like interferon-alpha, preferentially reduces the capacity for amplification of granulocyte-macrophage progenitors from patients with chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Studies of cellular proliferation in human leukemia. 3. Behavior of leukemic cells in three adults with acute leukemia given continuous infusions of 3H-thymidine for 8 or 10 days

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Co-detection of chimeric bcr/abl (target) and beta-actin (control) messenger RNA in individual CFU-GM colonies derived from CML patients using the polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Hydroxyurea versus busulfan in the treatment of chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Chronic myelogenous leukemia: is aggressive treatment indicated?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Response of chronic myelogenous leukemia patients to COAP-splenectomy. A Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Intensive combination chemotherapy (ROAP 10) and splenectomy in the management of chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

In-vitro effect of retinoic acid on normal and chronic myeloid leukemia granulopoiesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Therapeutic effects of low-dose cytosine arabinoside, alpha-interferon, 1 alpha-hydroxyvitamin D3 and retinoic acid in acute leukemia and myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Differentiation Therapy of Acute Promyelocytic Leukemia with Tretinoin (All-trans-Retinoic Acid)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Prognostic impact of interferon alpha-induced cytogenetic remission in chronic myelogenous leukaemia: long-term follow-up

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Persistence of BCR/ABL mRNA-expressing bone-marrow cells in patients with chronic myelogenous leukemia in complete cytogenetic remission induced by interferon-alpha therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Mechanism of action of alpha interferon in chronic granulocytic leukaemia: evidence for preferential inhibition of late progenitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

The molecular pathogenesis of the Philadelphia-positive leukemias: implications for diagnosis and therapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Interferon alfa-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia. French Chronic Myeloid Leukemia Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: a report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Allografting for chronic myeloid leukaemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Philadelphia chromosome-positive cells are equally distributed in AC133+ and AC133- fractions of CD34+ peripheral blood progenitor cells from patients with CML

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Autologous transplants for chronic myelogenous leukaemia: results from eight transplant groups

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Role of alpha1 acid glycoprotein in the in vivo resistance of human BCR-ABL(+) leukemic cells to the abl inhibitor STI571

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Recent advances in Philadelphia chromosome-positive malignancies: the potential role of arsenic trioxide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Initiation of deregulated growth of multipotent progenitor cells by bcr-abl in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Primitive human hematopoietic progenitor cells express receptors for granulocyte-macrophage colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Expression of lineage markers by CD34+ hematopoietic stem cells of adult mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Functional, phenotypic and molecular characterization of cytokine low-responding circulating CD34+ haemopoietic progenitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Treatment of acute leukemia in adults

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Treatment of adult acute leukemia with arabinosylcytosine and thioguanine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Long-term survivors in acute leukemia and Burkitt's tumor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Intensive chemotherapy in children with acute lymphoblastic leukemia (L-2 protocol)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402912

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2402912

1 reference

6 August 2017

1 reference